Genomic Health's Q1 Revenues Climb 17 Percent, Net Loss Turns to Profit | GenomeWeb

NEW YORK (GenomeWeb News) – Genomic Health's first-quarter revenues rose 17 percent year over year, the company reported after the close of the market on Wednesday.

For the three months ended March 31, total revenues increased to $58.5 million, compared to $49.8 million for Q1 2011 and exceeding consensus analyst estimates of $56.3 million.

Product revenues, which make up most of the revenues, also increased 17 percent year over year to $57.9 million from $49.5 million, while contract revenues rose 60 percent to $563,000 from $352,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.